IPO 2022 on the NASDAQ: here we are again with 2 biotechnologies, CinCor Pharma and Amylyx Pharmaceuticals, January 7, 2022
Two biotechnology companies developing innovative drugs will open IPO 2022 ball at the same time. CinCor Pharma and Amylyx Pharmaceuticals will join borse January 7… Read More »IPO 2022 on the NASDAQ: here we are again with 2 biotechnologies, CinCor Pharma and Amylyx Pharmaceuticals, January 7, 2022